Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults

International Journal of STD and AIDS

Volumn 24, Issue 10, 2013, Pages 775-779

  Sultan, B ^a   Benn, P ^b   Mahungu, T ^c   Young, M ^b   Mercey, D ^b   Morris Jones, S ^c   Miller, RF ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

AIDS; HIV; IGRA; Interferon gamma release assays; latent tuberculosis infection; Mycobacterium tuberculosis; screening; tuberculin skin test

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAMMA INTERFERON;

ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD;

EID: 84887365949     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413486459     Document Type: Article

References (19)

1. Chee CB-E,Sester M,Zhang W, et al.Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.Respirology. 2013;18:206-216.
2. Corbett EL,Watt CJ,Walker N, et al.The growing burden of tuberculosis: global trends and interaction with the HIV epidemic.Arch Intern Med. 2003;163:1009-1021.
3. Horsburgh CR.Priorities for the treatment of latent tuberculosis infection in the United States.N Engl J Med. 2004;350:2060-2067.
4. Redelman-Sidi G,Sepkowitz KA.Interferon gamma release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.Am J Respir Crit Care Med.
5. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010.MMWR Morbid Mortal Wkly Rep. 2010;59 (RR-5): 1-25.
6. National Institute for Health and Clinical Excellence. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. CG117. London: National Institute for Health and Clinical Excellence, 2011. http://publications.nice.org.uk/tuberculosis-cg117 (accessed 23 February 2013).
7. Cattamanchi A,Smith R,Steingart KR, et al.Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.J Acquir Immune Defic Syndr. 2011;56:230-238.
8. Sester M,Sotgiu G,Lange C, et al.Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.Eur Respir J. 2011;37:100-111.
9. Talati NJ,Seybold U,Humphrey B, et al.Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.BMC Infect Dis. 2009;9:15-15.
10. Ramos JM,Robledano C,Masiá M, et al.Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.BMC Infect Dis. 2012;12:169-169.
11. Richeldi L,Losi M,D'Amico R, et al.Performance of tests for latent tuberculosis in different groups of immunocompromised patients.Chest. 2009;136:198-204.
12. Rivas I,Latore I,Sanvisens A, et al.Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers.Epidemiol Infect. 2009;137:1342-1347.
13. Landis JR,Koch GC.The measurement of observer agreement for categorical data.Biometrics. 1977;33:159-174.
14. Harte D,Dosekun O,Sethi G, et al.Immunosuppression among HIV-1 positive patients attending for care: experience from 2 large HIV centres in the UK.HIV Med. 2010;11:114-120.
15. Clark SA,Martin SL,Pozniak A, et al.Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.Clin Exp Immunol. 2007;150:238-244.
16. Dheda K,Lalvani A,Miller RF, et al.Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count.AIDS. 2005;19:2038-2041.
17. Kall MM,Coyne KM,Garrett NJ, et al.Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study.BMC Infect Dis. 2012;12:107-107.
18. Garrett D, Katz D and Chideya S. Prospective comparison of the tuberculin skin test and interferon-gamma release assays in diagnosing infection with Mycobacterium tuberculosis and in predicting progression to tuberculosis. http://www.clinicaltrials.gov/ct2/results?term=NCT01622140 (accessed 23 February 2013).
19. Pozniak AL,Coyne KM,Miller RF, et al.BHIVA Guidelines Subcommittee. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.HIV Med. 2011;12:517-524.